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ESTIMATING THE EFFECT OF MULTIPLE IMPUTATION ON INCOMPLETE 
LONGITUDINAL DATA WITH APPLICATION TO A RANDOMIZED CLINICAL 
STUDY 
 
Abstract 
 For analyzing incomplete longitudinal data, there has been a recent interest in 
comparing estimates with and without the use of multiple imputation along with mixed 
effects model and generalized estimating equations. Empirically, the additional use of 
multiple imputation generally led to overestimated variances and may yield more heavily 
biased estimates than the use of last observation carried forward. Under ignorable or non-
ignorable missing, mixed effects model or generalized estimating equations alone yielded 
more unbiased estimates.  The different methods were also assessed in a randomized 
controlled clinical trial. 
 
Key Words: Generalized estimating equations; Missing values; Mixed effects model 
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1. INTRODUCTION 
Missing values are a fact of life in experimental studies. They are frequently 
encountered in clinical trials with repeated measurements for many reasons, including 
subject dropouts, noncompliance, and adverse events. Missing values can be classified as 
missing completely at random (MCAR) when the probability of having a missing value 
does not depend on the observed values or on the missing values had they been observed, 
missing at random (MAR) when the probability depends only on the observed values, or 
missing not at random (MNAR) when the probability depends only on the missing values 
had they been observed (Rubin, 1976).  
In superiority trials, the clear consensus has been to require use of the intention-to-
treat (ITT) principle to analyze all randomized subjects, regardless of whether data for the 
subjects were measured at all follow-up visits. This practice reduces the risk of 
overestimating the efficacy of a treatment, especially when data are MAR or MNAR (ICH, 
1998).  Common methods of longitudinal data analysis consistent with the ITT principle 
are the mixed effects model (MEM) and generalized estimating equations (GEE) (Chan et 
al., 2005; Dahmen & Ziegler, 2004; Edwards, 2000; Goldstein, Browne, & Rasbash, 2002; 
Wagner et al., 2005). The MEM is a conditional or subject-specific model, whereas the 
GEE is a marginal or population-averaged model. The models differ in the way the effects 
are interpreted, and there has been controversy about their use in analyzing longitudinal 
data (Carriere & Bouyer, 2002; Heagerty, 2002; Lee & Nelder, 2004; Lindsey & Lambert, 
1998). Nevertheless, the two methods often produce similar estimates and standard errors 
when missing values are MCAR or MAR, despite their unpredictable results for 
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dichotomous outcomes (Twisk, 2004). Moreover, it was recently argued that the difference 
in interpreting conditional and marginal estimates is meaningless, and marginal predictions 
can often be made from conditional models (Heagerty, 2002; Lee & Nelder, 2004; Lindsey, 
2000). Therefore, the MEM and GEE appear comparable for the analysis of incomplete 
longitudinal data.  
Alternatively, missing values could be imputed so that methods such as the 
repeated measures analysis of variance (ANOVA), which accommodate only subjects with 
complete observations, can be used. Imputation methods can generally be classified as 
single imputation (e.g., the last observation carried forward [LOCF]), when imputation is 
performed once, or multiple imputation (MI) when imputation is performed more than 
once (Schafer, 1999). Single imputation methods do not take into account the uncertainty 
about the values imputed. In general, they may also vary widely in their assumptions and 
may be used without due consideration of their appropriateness (Wood, White, Hillsdon, & 
Carpenter, 2005). Moreover, the use of single imputation may often lead to larger bias than 
MI in longitudinal data analysis (Shieh, 2003).  
Although imputation methods were developed to facilitate methods that analyze 
only subjects with complete observations, there has been a recent interest in examining the 
use of imputation methods together with MEM or GEE (Kang, Kraft, Gauderman, & 
Thomas, 2003; Shieh, 2003; Twisk & de Vente, 2002). Kang et al. (2003) showed that MI 
with MEM may yield biased variance component estimates in real and simulated 
longitudinal datasets. Shieh (2003) conducted a simulation study examining various 
imputation methods with MEM in analyzing cohort studies with MCAR and MAR values 
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and concluded that the use of MEM alone on all available subjects was an effective and 
flexible way to deal with missing values. The same conclusion was also derived in a 
dataset on orthodontic growth (Beunckens, Molenberghs, & Kenward, 2005). However, 
they had not examined the situation when values are MNAR.  Twisk & de Vente (2002) 
evaluated the use of imputation methods with GEE. They considered a dataset from the 
Amsterdam Growth and Health study, an observational longitudinal study, with and 
without generating MCAR, MAR, and MNAR values to compare seven imputation 
methods with GEE. They found that using MI with GEE produced comparable estimates 
but generally larger standard errors than using GEE without imputation. Therefore, they 
concluded that the use of GEE alone was adequate.  However, they focused on the analysis 
on a real dataset and results may not be generalized to other situations. 
In summary, two issues have not been sufficiently examined in the literature. First, 
the use of MI with MEM or GEE has not been adequately tested in a clinical trial setting in 
which the objective was to determine the treatment effect in specific epochs, which is 
common in clinical trials. Examining this would provide a more complete picture of the 
performance of analysis strategies in clinical trials to facilitate the preparation of a 
statistical analysis plan. Second, to our knowledge, the performance of MI with MEM or 
GEE when values were MNAR and with GEE under all missing value scenarios had not 
been assessed by simulation. Therefore, we aimed to assess the performance of the MEM 
and GEE methods with and without MI in estimating treatment effects on a continuous 
outcome during different epochs by using simulation and a real dataset from a randomized 
clinical study.  
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2. THE SETTING 
We consider the setting of a typical clinical trial in which n  study subjects are 
randomly allocated to receive either a test or a control treatment and are followed up for T  
visits after the baseline visit. For subject i  ( i  = 1, 2, …, n ), let ity  be the observation at 
visit t  ( t  = 0, 1, …, T ) and ig  be an indicator for the allocated group (0 for the control 
group or 1 for the treatment group). Without a loss of generality, we assume ity  may be 
missing in any follow-up visits except for the baseline visit. The pattern of missing values 
is not restricted and may occur intermittently. That is, a subject with ity  missing in one 
visit may or may not have values missing in subsequent visits. 
In this setting, we consider the objective of estimating the treatment effect at a 
follow-up visit, which is often pursued after adjusting for the baseline value. Before we 
discuss the methods of analysis, we further define the dummy variables 1=kitv  if kt =  and 
0=kitv  if otherwise, for k  = 1, 2, …, 1−T . That is, kitv  indicates the t th measurement 
from subject i taken at visit k .  
 
2.1. Analysis by MEM or GEE 
The following linear MEM with adjustment for baseline value is considered: 
 ijiiitiitiit eaggyy ++++++= νγγνγγµ
TT
32100   (1) 
for i  = 1, 2, …, n ; t  = 1, 2, …, T , where 𝜈𝑖𝑡 = (𝜈𝑖𝑡1 , 𝜈𝑖𝑡2 , … , 𝜈𝑖𝑡𝑇−1, 0)⊺, 
T)...,,,( 112111 Tγγγγ = , T)...,,,( 332313 Tγγγγ = , and ),0(~
2
ai Na σ  and ),0(~
2σNeit  are 
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statistically independent. The incorporation of 𝜈𝑖𝑡 in (1) allows the estimation of treatment 
effect at each clinical visit..  The ia  is the random effect used to account for subject-to-
subject heterogeneity, which induces an exchangeable correlation structure for the 
responses from the follow-up visits. Note that (1) may also be written as 
iiii ebXY ++= β
T ; ),0(~),11,0(~ 22 TiTTai INeNb σσ T  
where T),...,,( 21 iTiii yyyY = , ),...,,( 21 iTiii xxxX = , TTT ),,,,1( 0 iitiitiit ggyx νν= , 
TTT ),,,,( 3210 γγγγµβ i= , T1  is the 1×T  vector of 1, and TI  is the TT ×  identity matrix.  
Estimation of the unknown parameters is often pursuit by restricted maximum likelihood 
or maximum likelihood.   
For the analysis by GEE, we need to specify the first two moments of ity . Specifically, 
we consider 
 βTititit xxyE =)|( , 
2)|( σ=itit xyVar   (2) 
for t  = 1, 2, …, T , and an exchangeable working covariance matrix W .  Estimate of β  is 
then obtained by solving the GEE 0)(1
1
1
2 =−∑
=
−
n
i
iii XYWXn
β
σ
TT . 
In either (1) or (2), the treatment effect at visit t  ( t  = 1, 2, …, 1−T ) is given by 
t32 γγ +  and the effect at visit T  is 2γ . They are denoted by tθ , for t  = 1, 2, …, T . The 
code used in Statistical Analysis System (SAS) Version 9.2 for the analysis is provided in 
Appendix A. 
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2.2. Analysis by Using LOCF with MEM or GEE 
The analysis is performed by replacing the missing values using the LOCF 
approach (i.e., the last observed value before a missing value is used to impute the missing 
value) before the MEM in (1) or the GEE in (2). 
 
2.3. Analysis by using MI with MEM or GEE 
The MI proceeds by first imputing the missing values for m  (> 1) times, and 
thereby generates m  complete datasets. This is opposed to single imputation which does 
not account the uncertainty due to imputation. There are various imputation methods 
depending on the missing value pattern (Rubin, 1987; Yang, Li, & Shoptaw, 2008).  
Because any intermittent ity  for a subject may be missing, the Markov Chain Monte Carlo 
(MCMC) method is used for imputation.(Schafer, 1997) In each imputation, the MCMC 
method generates a chain of sequentially associated values until they stabilized and the 
converged values are used to impute the missing values (Schafer, 1997).  Then, each of the 
m  complete datasets is analyzed by the linear MEM in (1) or the GEE in (2); thereby, m  
sets of parameter estimates are obtained. The m  sets of estimates are combined for 
inference about tθ . Specifically, if 
b
tθˆ  and btωˆ ),,2,1( mb =  are respectively the 
estimate and estimated variance of tθ  from the b th dataset, the combined estimate and 
variance estimate of tθ  are ∑
=
=
m
b
b
tt m 1
ˆ1 θθ  and 





−
−
+
+= ∑∑
==
m
b
t
b
t
m
b
b
tt mm
m
m 1
2
1
)(
1
11ˆ1 θθωω , 
respectively.(Schafer, 1997)  Note however the MCMC method is adequate only when 
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missing values are at most MAR.  This facilitates fair comparisons with the use of MEM 
and GEE alone, which are valid only up to MAR and MCAR respectively.  
In our applications, m  is taken as 5 and 500 to assess the effects of using small and 
moderate sizes of imputations.  The SAS code used for the analysis is provided in 
Appendix A. 
 
3. DATA GENERATION AND ASSESSMENTS 
The simulation study was programmed in SAS. Generation of the data was based 
on the setting of a clinical trial described in Section 2. The number of follow-up visits T  
was assumed to be 3. Then, 3,2,1,0}{ =tity  was generated from 
ititiiit egyay +++= θ0  
for t  = 1, 2, 3, where 0iy , ia  and ite  were identically and independently distributed as 
)1,0(N . That is, conditioned on 0iy , ),,( 321 iii yyy  followed a multivariate normal 
distribution with mean ig),,( 321 θθθ  and covariance matrix T333 11+= IV .  
The ),,( 321 θθθ  represented the treatment effect at the three follow-up visits, which 
was taken as (1, 0.5, 0) and (1, 0, 0). The first corresponds to a steady decrease of 
treatment effect, which does not favor the use of LOCF to handle missing values at all 
visits. The second corresponds to a sharply diminished treatment effect at the second 
follow-up visit but no change between visits 2 and 3, which favors the use of LOCF to 
handle missing values at the third follow-up visit. The generated dataset had no missing 
values and was referred as the complete dataset.  
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Then, incomplete datasets under the three missing value scenarios were generated 
from the complete dataset. Without a loss of generality, only values at visits 1, 2, and 3 of 
the complete dataset could be made missing. By specifying %100×mp  of missing values 
to be generated, a dataset with MCAR values (MCAR dataset) was obtained by randomly 
deleting values from the complete dataset with probability mp . To generate a dataset with 
MAR values (MAR dataset), values in a visit were deleted if they corresponded to the 
upper %100×mp  observed values in the previous visit. For the dataset with MNAR values 
(MNAR dataset), the upper %100×mp  of values in each visit were deleted. The mp  was 
chosen as 0.30. 
The number of subjects, n , was assumed to be 200 with 100 subjects in each group. 
With this sample size, the powers of detecting treatment effects of 1 at visit 1 and 0.5 at 
visit 2 were 0.9988 and 0.7054, respectively, when either the GEE or the linear MEM was 
used. Thus, the sample size would enable us to examine the performance of various 
methods when the power was high or of moderate size. When 30% of the values were 
MCAR, the powers became 0.9869 and 0.5524, respectively, and thus exaggerated the 
difference in power. Details of the calculation are shown in Appendix B. Note: We did not 
calculate the power when values were MAR and MNAR, because those situations may 
result in biased estimates and the power would not really reflect the chance of detecting a 
discernible effect. 
The data generation procedure was repeated to generate 1000 sets of complete and 
missing datasets under various missing value scenarios. By denoting them as ( s1ˆθ , s2ˆθ , s3ˆθ ) 
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( s  = 1, 2, …, 1000), the following summary statistics were computed for assessing each 
method of analysis.  
1. Mean estimate, i.e. 1000/ˆ1000
1 1∑ =s sθ , 1000/ˆ
1000
1 2∑ =s sθ  and 1000/ˆ
1000
1 3∑ =s sθ . 
2. SE, the square root of the mean estimated variances of the estimates. 
3. Bias, i.e. 1
1000
1 1
1000/ˆ θθ −∑ =s s , 2
1000
1 2
1000/ˆ θθ −∑ =s s  and 3
1000
1 3
1000/ˆ θθ −∑ =s s . 
4. Mean squared error (MSE), i.e. 1000/)ˆ( 21
1000
1 1
θθ −∑ =s s , 1000/)ˆ( 22
1000
1 2
θθ −∑ =s s  and 
1000/)ˆ( 23
1000
1 3
θθ −∑ =s s . The MSE measures the sampling variance of each estimator. 
5. Ratio, i.e., a mean estimated variance divided by the corresponding sampling variance. 
6. 95% coverage, i.e., the proportion of estimated 95% confidence intervals covering the 
corresponding true values. 
 
4. SIMULATION RESULTS 
Table 1 compares the bias of various methods of estimating treatment effects across 
visits under the three missing value scenarios when ),,( 321 θθθ  = (1, 0.5, 0) and the number 
of imputations was 5.  
Under MCAR, the MEM and GEE methods yielded unbiased estimates, but any 
combination of the LOCF or MI with either the MEM or the GEE method resulted in 
substantial biases in all visits. The bias was the largest when LOCF was used. At visit 1, 
when LOCF was used, a missing value from a subject was replaced by the observed value 
of the subject at visit 0. Hence, the imputed value was 0, on average, for both the control 
and treatment groups. Therefore, treatment effect at visit 1 was underestimated. By the 
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same token at visit 2, the use of LOCF led to overestimation of the treatment effect 
because missing values in the treatment group were imputed mostly by 1, which is larger 
than the true value of 0.5, whereas missing values in the control group were still mostly 
imputed by 0. Similarly, using LOCF also overestimated the treatment effect at visit 3. In 
contrast, MI for a missing value of a subject made use of all observed values from visits 
other than when the value was missing. Therefore, naïve expected values used to impute 
missing values at visits 1, 2, and 3 would be (0+0.5+0)/3 = 0.17, (0+1+0)/3 = 0.33, and 
(0+1+0.5)/3 = 0.50, respectively, for the treatment group, and all 0s for the control group. 
With the true treatment effects of ),,( 321 θθθ  = (1, 0.5, 0) and 30% missing values, the 
biases at the three follow-up visits should be approximately (0.17–1)(0.3) = –0.25, (0.33–
0.5)(0.3) = –0.05 and (0.50–0)(0.3) = 0.15, respectively. These values were consistent with 
those reported in Table 1. Subsequently, we envisaged that MI may yield a larger bias than 
LOCF when the last observation was closer to the true value of the missing value than the 
average of observations from all other visits was. Indeed, in the simulation study with 
),,( 321 θθθ  = (1, 0, 0), treatment effect at visit 3 was slightly more overly estimated by MI 
(bias = 0.0668) than by LOCF (bias = 0.0619). Regarding the precision of the estimates, 
SEs from all methods were only moderately higher than the corresponding values in the 
analysis of complete datasets. 
Under MAR, there was a very slightly higher general bias by the MEM and GEE 
methods, but the estimates remained essentially unbiased. The LOCF and MI again yielded 
substantially biased estimates. However, MI under MAR resulted in smaller bias as well as 
a smaller SE than under MCAR because the accuracy of imputation by other observed 
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values was expectedly higher when the probability of data missing is in fact related to the 
observed values.  
Under MNAR, there was a general reduction in SEs due to reduced variance 
resulted from deleting “large” values. However, there was considerable bias in all methods 
and a general underestimation of treatment effects when the treatment effect was positive 
(i.e., at visits 1 and 2). This happened because values in the treatment group were likely to 
be higher than those in the control group and thus more likely to be missing. Bias from the 
use of MEM or GEE alone remained the smallest when treatment effect was positive. At 
visit 3 when there was no hypothesized treatment effect, the bias was smaller because 
values in the two groups had equal probabilities of being missing.  
In general, the MEM and GEE methods behaved very similarly, regardless of 
whether LOCF or MI was used and regardless of missing value scenarios. SEs when LOCF 
was used were generally smaller than those resulting from the other methods due to the use 
of initial values for imputation that increased the estimation precision when the initial 
value was also adjusted in the analysis. 
Table 2 shows the performance of the methods of analysis on MSE, ratio and 95% 
coverage under the various missing value scenarios when ),,( 321 θθθ  = (1, 0.5, 0). Under 
MCAR or MAR, the use of LOCF resulted in the poorest MSE and 95% coverage. 
Although MI may yield a smaller MSE than the other methods, it had a more overly 
estimated variance. MEM and GEE used alone gave small MSEs, did not severely 
underestimate the variance compared with the sampling variance, and had good coverage. 
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Under MNAR when there were positive treatment effects at visits 1 and 2, the MSE 
was generally inflated due to the increase in bias. Particularly, both LOCF and MI resulted 
in inaccurate estimated variance compared with the sampling variance and thus yielded 
poor 95% coverage. In contrast, MEM and GEE used alone gave unbiased variance 
estimates, and the corresponding 95% coverage was the best compared with other methods, 
regardless of whether there was a positive treatment effect.  
When the number of imputations used in MI was 500, similar results were obtained. 
When ),,( 321 θθθ  = (1, 0, 0), similar phenomena were also observed except where 
indicated. 
 
5. AN EXAMPLE 
A randomized, controlled clinical trial was conducted to examine the effects of the 
Chinese exercise qigong vs. a control exercise in patients with type 2 diabetes mellitus 
(Lee et al., 2003; Lee et al., 2002). The study was conducted in the Queen Mary Hospital 
of Hong Kong with a study protocol and informed consent forms approved by the 
hospital’s Research Ethics Committee. 
There were several outcomes of interest, but we focused only on measurements 
taken by the 36-item Medical Outcome Study Short Form (Hong Kong version), a generic 
health-related quality of life questionnaire making up eight distinct constructs: physical 
function (PF), social function (SF), role physical (RP), role emotional (RE), vitality (VT), 
mental health (MH), general health (GH), and bodily pain (BP). The questionnaire was 
administered to 100 study patients (37 men and 63 women) before randomization, as well 
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as 6, 10, and 18 weeks afterward. Patients allocated to the qigong group learned qigong 
during the first four weeks and were advised to practice qigong daily. Effects of qigong on 
the eight scales have been examined elsewhere (Lee et al., 2002). In particular, there was 
no evidence that qigong improved PF. However, it is of interest to examine whether men 
or women, after practicing qigong, had more improvement in PF. Therefore, we focused on 
the analysis of how the patient’s sex affected PF over time in the 50 patients (27 men and 
23 women) who practiced qigong.  
Of the 50 patients, one dropped out after randomization and another withdrew after 
week 10. Therefore, there were only a few missing values in the raw dataset, and their 
effects were deemed negligible. About 15% of missing values were generated using the 
MCAR, MAR, and MNAR scenarios, and the MEM and GEE with and without LOCF and 
MI were applied.  
Table 3 summarizes the estimated effect of the patient’s sex on PF at each visit. 
Based on the analysis of the raw dataset, female patients had higher PF values than male 
patients at 10 weeks but not at other visits.  
Under the missing value scenarios used in our estimates, the use of MEM and GEE 
alone on the incomplete datasets generally provided the same conclusions as when they 
were applied on the raw dataset. In contrast, the additional use of LOCF or MI generally 
yielded substantially different p-values or estimates. In particular, LOCF gave a few false-
positive errors because it generally led to biased estimates. The MI generally led to 
insignificant results along with larger standard errors. MI yielded, at visit 3 in the MCAR 
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dataset, a biased estimate higher than that of LOCF. Therefore, the use of MEM or GEE 
alone appeared to be sufficient.  
 
6. DISCUSSIONS 
In response to the recent interest in examining the use of MI together with MEM or 
GEE, we performed the first simulation study to assess the use of MI with GEE for 
longitudinal analysis when there are missing values.  Moreover, we also assessed for the 
first time, the performance of using MI with MEM when values are MNAR.  When MEM 
or GEE are used for the analysis of incomplete longitudinal trials, the use of LOCF or MI 
appears to be unnecessary under all missing value scenarios. 
In general, using LOCF with either MEM or GEE may lead to substantial bias 
compared with other methods. The bias resulting from using LOCF in longitudinal studies 
has been well documented in the literature (Cook, Zeng, & Yi, 2004; Liu & Gould, 2002; 
Siddiqui & Ali, 1998). Despite this, LOCF has been very commonly used in the analysis of 
clinical trials. MI emerged as an attractive alternative imputation method, taking into 
account the uncertainty about the imputed values. However, in our simulation study, the 
use of MI with MEM or GEE also resulted in biased effect estimates. The bias may even 
be worse than that of LOCF in certain scenarios under the MCAR, a missing value 
scenario often considered negligible. Moreover, MI often yields overestimated variances, 
possibly due to imputation uncertainty. Nielsen (2003) showed that multiple imputation 
methods can sometimes be improper and that even a proper multiple imputation method 
can be inefficient. Moreover, the use of different methods of handling missing values may 
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influence sample size requirements (Auleley et al., 2004). Therefore, the use of MEM or 
GEE without MI or LOCF is generally sufficient.  
When values are MNAR, the use of MEM or GEE alone may result in considerable 
bias. Because MNAR and MAR are, unfortunately, indistinguishable unless external 
information about the missing value scenario is available, sensitivity analysis is often 
advisable to guard against having overly optimistic treatment effect estimates 
(Molenberghs et al., 2004). The sensitivity analysis can be performed on different sets of 
subjects according to their compliance, or imputation methods that have a predictable 
direction of bias (e.g., the worst-case method, in which missing values in the treatment and 
control groups are replaced by the respective worst- and best-case values) can be used.  
Nevertheless, the use of MI by MCMC would generally result in larger bias and poorer 
95% coverage.  Although the contrary was observed when treatment effect is nil, the bias 
was small and the coverage was reasonable when only MEM or GEE was used.  Therefore, 
the use of MI by MCMC does not remarkably improve the estimation of treatment effects.  
Note however we have not assessed the use of MI by algorithms based on MNAR as this 
does not enable a fair comparison with the use of MEM or GEE alone which is only valid 
up to MAR or MCAR respectively (Yang et al., 2008).   
There were no notable differences in the results between the use of 5 and 500 
imputations.  Generally, the number of imputations should be guided by the relative 
efficiency.  However, there is often no practical benefit to using more than 5 to 10 
imputations unless missing values are unusually many (Schafer, 1999).  Indeed, with 50% 
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missing values, the relative efficiency for using 5 imputations is 1.049 which is not 
remarkable. 
Although it was not our intention to compare MEM and GEE in our simulation 
study, we did find that the two methods performed quite similarly in all missing value 
scenarios. However, we examined only situations in which correlations among the repeated 
measurements were exchangeable. GEE has the well-known flexibility and robustness to 
be the choice of the covariance matrix for repeated measurements, but it assumes the 
MCAR scenario. On the other hand, MEM may also accommodate a wide range of 
covariance structures by using random effects (Fong, Lam, Lawless, & Lee, 2001; Lawless 
& Fong, 1999). Moreover, MEM uses likelihood-based inference and thus produces 
consistent estimates under both MCAR and MAR. In general, MEM appears to have more 
advantages for the analysis of explicative studies. 
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APPENDIX A: SAS CODE FOR THE ESTIMATION METHODS USED 
ID is the subject identification number, VISIT is the number of the visit (0, 1, 2, 3), 
GROUP is the number of the treatment group (0 = control; 1 = treatment), SCORE0 is the 
baseline measurement, and SCOREn is the measurement at visit number n. 
1. The SAS code for the analysis by the linear MEM given in (1) is: 
proc mixed; 
   class ID VISIT GROUP; 
   model SCORE = SCORE0 VISIT GROUP VISIT*GROUP ; 
   estimate 'Group at Visit 1'   GROUP –1 1 VISIT*GROUP –1 1 0 0 0 0; 
   estimate 'Group at Visit 2'   GROUP –1 1 VISIT*GROUP 0 0 –1 1 0 0; 
   estimate 'Group at Visit 3'   GROUP –1 1 VISIT*GROUP 0 0 0 0 –1 1; 
   random  intercept /subject=ID; 
run;  
 
2. The SAS code for the analysis by the GEE given in (2) is: 
proc genmod; 
   class ID VISIT GROUP; 
   model SCORE = SCORE0 VISIT GROUP VISIT*GROUP; 
      estimate 'Group at Visit 1'   GROUP –1 1 VISIT*GROUP –1 1 0 0 0 0; 
      estimate 'Group at Visit 2'   GROUP –1 1 VISIT*GROUP 0 0 –1 1 0 0; 
      estimate 'Group at Visit 3'   GROUP –1 1 VISIT*GROUP 0 0 0 0 –1 1; 
   repeated subject=ID /type=exch; 
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run; 
 
3. The SAS code for the analysis by MI and MEM is: 
proc mi out=sim.mi nimpute=5 seed=18039; 
   var SCORE0–SCORE3; run; 
data sim.ana;  set sim.mi; 
   array dum [3] SCORE1 SCORE2 SCORE3; 
   do i = 2 to 4;      score = dum[i–1]; VISIT=i–1; output;       end; 
   drop SCORE1–SCORE3 i;  run; 
proc sort data=sim.ana;  by _imputation_ ID descending VISIT ; run; 
proc mixed data=sim.ana covtest noitprint noprofile noinfo noclprint; 
   by _imputation_; 
   class id VISIT GROUP; 
   model score = SCORE0 VISIT GROUP VISIT*GROUP /s covb; 
   random  intercept /subject=ID; 
   ods output solutionF=sim.sol covb=sim.covb; 
run;  
data sim.sol(type=EST); set sim.sol;   
   if effect='visit' and visit=1 then effect='visit1'; 
   if effect='visit' and visit=2 then effect='visit2'; 
   if effect='visit' and visit=3 then delete; 
   if effect='group' and group=0 then effect='group0'; 
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   if effect='group' and group=1 then delete; 
   if effect='visit*group' then do; 
      if visit=1 and group=0 then effect='v1_g0'; else 
      if visit=2 and group=0 then effect='v2_g0'; else delete; 
      end;  run; 
data sim.covb(type=covb); set sim.covb;   
   if effect='visit' and visit=1 then effect='visit1'; 
   if effect='visit' and visit=2 then effect='visit2'; 
   if effect='visit' and visit=3 then delete; 
   if effect='group' and group=0 then effect='group0'; 
   if effect='group' and group=1 then delete; 
   if effect='visit*group' then do; 
      if visit=1 and group=0 then effect='v1_g0'; else 
      if visit=2 and group=0 then effect='v2_g0'; else delete; 
      end;   
   drop col5 col7 col9 col11–col13; 
   rename col6=Col5 col8=Col6 col10=Col7; 
   if row=6 then row=5;  if row=8 then row=6; if row=10 then row=7; 
run; 
 
proc mianalyze parms=sim.sol covb(effectvar=rowcol)=sim.covb; 
   modeleffects intercept score0 visit1 visit2 group0 v1_g0 v2_g0; 
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   Group: test –group0–v1_g0, –group0–v2_g0, –group0; 
run; 
 
4. The SAS code for the analysis by MI and GEE is: 
proc genmod data=sim.ana ; by _imputation_; 
   class ID VISIT GROUP; 
   model score = SCORE0 VISIT GROUP VISIT*GROUP /covb; 
   repeated subject=ID /type=exch; 
   ods output ParameterEstimates=sim.sol Covb=sim.covb ParmInfo=sim.info; 
run; 
data sim.sol;  set sim.sol; 
   if parameter='visit' and level1=1 then parameter='visit1'; 
   if parameter='visit' and level1=2 then parameter='visit2'; 
   if parameter='visit' and level1=3 then delete; 
   if parameter='group' and level1=0 then parameter='group0'; 
   if parameter='group' and level1=1 then delete; 
   if parameter='visit*group' then do; 
      if level1=1 and level2=0 then parameter='v1_g0'; else 
      if level1=2 and level2=0 then parameter='v2_g0'; else delete; 
      end;  run; 
data sim.covb(type=covb); set sim.covb; 
   rename Prm6=Prm5 Prm8=Prm6 Prm10=Prm7; 
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   if RowName='Prm6' then RowName='Prm5';  
   if RowName='Prm8'  then RowName='Prm6';  
   if RowName='Prm10' then RowName='Prm7'; run; 
data sim.info;  set sim.info; 
   if effect='visit' and visit=1 then effect='visit1'; 
   if effect='visit' and visit=2 then effect='visit2'; 
   if effect='visit' and visit=3 then delete; 
   if effect='group' and group=0 then effect='group0'; 
   if effect='group' and group=1 then delete; 
   if effect='visit*group' then do; 
      if visit=1 and group=0 then effect='v1_g0'; else 
      if visit=2 and group=0 then effect='v2_g0'; else delete; 
      end;  
   if Parameter='Prm6' then Parameter='Prm5';  
   if Parameter='Prm8' then Parameter='Prm6';  
   if Parameter='Prm10' then Parameter='Prm7'; run; 
 
proc mianalyze parms=sim.sol covb=sim.covb parminfo=sim.info; 
   modeleffects intercept SCORE0 VISIT1 VISIT2 GROUP0 v1_g0 v2_g0; 
   Group: test –group0–v1_g0, –group0–v2_g0, –group0; 
run; 
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APPENDIX B: POWER ANALYSES 
We aim to determine the power of detecting a treatment effect of size 0tθ  at visit t  
with a sample size of n  and a maximum false positive error rate of α  under Model (3). In 
the sequel, we concern the testing of  
0:0 =βtKH  against 0: ttA KH θβ =  
where tK  is the t
th row of the matrix 










0010000
1010000
0110000
. 
Estimate of β  may be obtained by using GEE, denoted by GEEβˆ , and linear MEM, 
denoted by MEMβˆ . 
When there are no missing values, GEEβˆ  asymptotically follows ),(
1
ββ Σ
−nN  
where  
)( 1
1
1
1 TXVXE −−=Σβ  
(Tu et al., 2007). )( 1
1
1
TXVXE −  can be easily evaluated with V  known, )1,0(~10 Ny  and 
)2/1,1(~1 Bing . Then, the power can be calculated as 
 )1(1 1)(21 αχ −−− pF c  (4) 
where ααχ −=− 1)( 1)0(21 pF , )(2 caFχ  represents the cumulative distribution function of a 
2χ  
distribution with a  degrees of freedom and noncentrality parameter c , and 
120 )()( −Σ= Tttt KKnc βθ . With 200=n  and 1
0
1 =θ , we have 8=Σ
T
tt KK β , 25=c  and 
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power = 0.9988. With 200=n  and 5.002 =θ , we have 8=Σ Ttt KK β , 25.6=c  and power = 
0.7054. On the other hand, MEMβˆ  asymptotically follows ),(
1
ββ Σ
−nN  again. Therefore, 
the power of using linear MEM is identical to that of using GEE. 
 When missing values are MCAR, let itr  be 1 if ity  is observed and 0 if otherwise. 
Then, with iR  = )( itrdiag  and 32IAi = , GEEβˆ  asymptotically follows ),(
1
ββ Σ
−nN  but 
now  
11 −− Σ=Σ BB Uβ  
where )( 1
1
111
TXARXEB −=  and )( 11111111 TXAVRRAXEU −−=Σ  (Tu et al., 2007). Again, 
with V  known, )1,0(~10 Ny , )2/1,1(~1 Bing  and )1,1(~11 mpBinr − , both B  and UΣ  
can be computed. Then, the power can be calculated as in (4). With 200=n , 3.0=mp  and 
101 =θ , we have 43.11=Σ
T
tt KK β , 5.17=c  and power = 0.9869. With 200=n , and 
5.002 =θ , we have 43.11=Σ
T
tt KK β , 375.4=c  and power = 0.5524. On the other hand, as 
in the case with no missing values, MEMβˆ  asymptotically follows ),(
1
ββ Σ
−nN  again and 
thus use of linear MEM results in the same power as in the use of GEE. 
 
 
 
27 
 
REFERENCES 
Auleley, G. R., Giraudeau, B., Baron, G., Maillefert, J. F., Dougados, M., & Ravaud, P. 
(2004). The methods for handling missing data in clinical trials influence sample size 
requirements. Journal of Clinical Epidemiology, 57(5):447-453. 
Beunckens, C., Molenberghs, G., & Kenward, M. G. (2005). Direct likelihood analysis 
versus simple forms of imputation for missing data in randomized clinical trials. 
Clinical Trials, 2:379-386. 
Carriere, I., & Bouyer, J. (2002). Choosing marginal or random-effects models for 
longitudinal binary responses: application to self-reported disability among older 
persons. BMC Medical Research Methodology, 2(1):15. 
Chan, Y. M., Lee, P. W., Fong, D. Y., Fung, A. S., Wu, L. Y., Choi, A. Y., Ng, T. Y., 
Ngan, H. Y., & Wong, L. C. (2005). Effect of individual psychological intervention in 
chinese women with gynecologic malignancy: a randomized controlled trial. Journal 
of Clinical Oncology, 23(22):4913-4924. 
Cook, R. J., Zeng, L., & Yi, G. Y. (2004). Marginal analysis of incomplete longitudinal 
binary data: a cautionary note on LOCF imputation. Biometrics, 60(3):820-828. 
Dahmen, G., & Ziegler, A. (2004). Generalized estimating equations in controlled clinical 
trials: Hypotheses testing. Biometrical Journal, 46(2):214-232. 
Edwards, L. J. (2000). Modern statistical techniques for the analysis of longitudinal data in 
biomedical research. Pediatric Pulmonology, 30(4):330-344. 
28 
 
Fong, D. Y., Lam, K. F., Lawless, J. F., & Lee, Y. W. (2001). Dynamic random effects 
models for times between repeated events. Lifetime Data Analysis, 7(4):345-362. 
Goldstein, H., Browne, W., & Rasbash, J. (2002). Multilevel modelling of medical data. 
Statistics in Medicine, 21(21):3291-3315. 
Heagerty, P. J. (2002). Marginalized transition models and likelihood inference for 
longitudinal categorical data. Biometrics, 58(2):342-351. 
ICH. (1998). E9: Statistical Principles for Clinical Trials Retrieved 16 Nov 2007, from 
http://www.ich.org/ 
Kang, T., Kraft, P., Gauderman, W. J., & Thomas, D. (2003). Multiple imputation methods 
for longitudinal blood pressure measurements from the Framingham Heart Study. 
BMC Genetics, 4 Suppl 1:S43. 
Lawless, J. F., & Fong, D. Y. T. (1999). State duration models in clinical and observational 
studies. Statistics in Medicine, 18(17-18):2365-2376. 
Lee, K. K., Leung, E., Fong, D., Wong, S., Tam, S. C. F., Wong, V., & Lam, K. S. L. 
(2003). The beneficial effects of Qigong and conventional exercise on blood pressure 
and anthropometric indices in type 2 Chinese diabetic patients. Hong Kong Medical 
Journal, 9 Suppl(1):34. 
Lee, K. K., Leung, E., Wong, S., Tam, S. C. F., Wong, V., & Lam, K. S. L. (2002). The 
effects of Qigong and conventional exercise on type 2 diabetic patients. Diabetes, 51 
Suppl(2):A245. 
29 
 
Lee, Y., & Nelder, J. (2004). Conditional and marginal models: Another view. Statistical 
Science, 19(2):219-228. 
Lindsey, J. K. (2000). Obtaining marginal estimates from conditional categorical repeated 
measurements models with missing data. Statistics in Medicine, 19(6):801-809. 
Lindsey, J. K., & Lambert, P. (1998). On the appropriateness of marginal models for 
repeated measurements in clinical trials. Statistics in Medicine, 17(4):447-469. 
Liu, G., & Gould, A. L. (2002). Comparison of alternative strategies for analysis of 
longitudinal trials with dropouts. Journal of Biopharmaceutical Statistics, 12(2):207-
226. 
Molenberghs, G., Thijs, H., Jansen, I., Beunckens, C., Kenward, M., Mallinckrodt, C., & 
Carroll, R. (2004). Analyzing incomplete longitudinal clinical trial data. Biostatistics, 
5(3):445-464. 
Nielsen, S. (2003). Proper and improper multiple imputation. International Statistical 
Review, 71(3):593-607. 
Rubin, D. B. (1976). Inference and Missing Data. Biometrika, 63(3):581-590. 
Rubin, D. B. (1987). Multiple imputation for nonresponse in surveys. New York: Wiley. 
Schafer, J. L. (1997). Analysis of incomplete multivariate data (1st ed.). London: Chapman 
& Hall. 
Schafer, J. L. (1999). Multiple imputation: a primer. Statistical Methods in Medical 
Research, 8(1):3-15. 
30 
 
Shieh, Y.-Y. (2003). Imputation methods on general linear mixed models of longitudinal 
studies, Federal Committee on Statistical Methodology Research Conference. 
Arlington Virginia. 
Siddiqui, O., & Ali, M. W. (1998). A comparison of the random-effects pattern mixture 
model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical 
trials with dropouts. Journal of Biopharmaceutical Statistics, 8(4):545-563. 
Tu, X. M., Zhang, J., Kowalski, J., Shults, J., Feng, C., Sun, W., & Tang, W. (2007). 
Power analyses for longitudinal study designs with missing data. Statistics in Medicine, 
26(15):2958-2981. 
Twisk, J., & de Vente, W. (2002). Attrition in longitudinal studies. How to deal with 
missing data. Journal of Clinical Epidemiology, 55(4):329-337. 
Twisk, J. W. (2004). Longitudinal data analysis. A comparison between generalized 
estimating equations and random coefficient analysis. European Journal of 
Epidemiology, 19(8):769-776. 
Wagner, A. K., Fabio, A., Puccio, A. M., Hirschberg, R., Li, W., Zafonte, R. D., & Marion, 
D. W. (2005). Gender associations with cerebrospinal fluid glutamate and 
lactate/pyruvate levels after severe traumatic brain injury. Critical Care Medicine, 
33(2):407-413. 
Wood, A. M., White, I. R., Hillsdon, M., & Carpenter, J. (2005). Comparison of 
imputation and modelling methods in the analysis of a physical activity trial with 
missing outcomes. International Journal of Epidemiology, 34(1):89-99. 
31 
 
Yang, X., Li, J., & Shoptaw, S. (2008). Imputation-based strategies for clinical trial 
longitudinal data with nonignorable missing values. Stat Med, 27(15):2826-2849. 
 
32 
 
Table 1. Comparisons of the bias of using last observation carried forward (LOCF) and multiple imputation (MI) on mixed effects model 
(MEM) and generalized estimating equations (GEE) under various missing value scenarios 
 
Treatment effect at Visit 1 
( 11 =θ )  
Treatment effect at Visit 2 
( 5.02 =θ )  
Treatment effect at Visit 3 
( 03 =θ ) 
 Mean estimate SE** Bias  Mean estimate SE** Bias  Mean estimate SE** Bias 
Complete Dataset            
MEM 1.0044 0.2003 0.0044  0.5033 0.2003 0.0033  –0.0011 0.2003 –0.0011 
GEE 1.0044 0.1992 0.0044  0.5033 0.1989 0.0033  –0.0011 0.1989 –0.0011 
MCAR Dataset*            
MEM 1.0008 0.2297 0.0008  0.4979 0.2297 –0.0021  –0.0007 0.2297 –0.0007 
GEE 1.0007 0.2279 0.0007  0.4978 0.2277 –0.0022  –0.0008 0.2275 –0.0008 
LOCF + MEM 0.7032 0.1970 –0.2968  0.5762 0.1970 0.0762  0.1705 0.1970 0.1705 
LOCF + GEE 0.7032 0.1730 –0.2968  0.5762 0.2088 0.0762  0.1705 0.2035 0.1705 
MI + MEM 0.7482 0.2310 –0.2518  0.4317 0.2292 –0.0683  0.1054 0.2295 0.1054 
MI + GEE 0.7482 0.2297 –0.2518  0.4317 0.2278 –0.0683  0.1054 0.2282 0.1054 
MAR Dataset*            
MEM 1.0013 0.2289 0.0013  0.5063 0.2111 0.0063  0.0012 0.2219 0.0012 
GEE 1.0019 0.2277 0.0019  0.5021 0.2090 0.0021  0.0031 0.2200 0.0031 
LOCF + MEM 0.7005 0.2010 –0.2995  0.6674 0.2010 0.1674  0.1280 0.2010 0.1280 
LOCF + GEE 0.7005 0.1728 –0.2995  0.6674 0.2142 0.1674  0.1280 0.2094 0.1280 
MI + MEM 0.7714 0.2296 –0.2286  0.4871 0.2165 –0.0129  0.0723 0.2246 0.0723 
MI + GEE 0.7714 0.2282 –0.2286  0.4871 0.2151 –0.0129  0.0723 0.2232 0.0723 
MNAR Dataset*            
MEM 0.6431 0.1839 –0.3569  0.3024 0.1827 –0.1976  –0.0346 0.1822 –0.0346 
GEE 0.6464 0.1814 –0.3536  0.3023 0.1796 –0.1977  –0.0380 0.1793 –0.0380 
LOCF + MEM 0.4864 0.1563 –0.5136  0.1744 0.1564 –0.3256  –0.0382 0.1564 –0.0382 
LOCF + GEE 0.4864 0.1391 –0.5136  0.1744 0.1655 –0.3256  –0.0382 0.1604 –0.0382 
MI + MEM 0.4528 0.1831 –0.5472  0.2325 0.1811 –0.2675  0.0072 0.1797 0.0072 
MI + GEE 0.4528 0.1822 –0.5472  0.2325 0.1801 –0.2675  0.0072 0.1788 0.0072 
*MCAR, missing completely at random; MAR, missing at random; MNAR, missing not at random. 
**SE, square root of the mean estimated variance over all generations of data.  
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Table 2. Comparisons of the mean squared error (MSE) and the 95% coverage of using last observation carried forward (LOCF) and 
multiple imputation (MI) on mixed effects model (MEM) and generalized estimating equations (GEE) under various missing value 
scenarios 
 
Treatment effect at Visit 1 
( 11 =θ )  
Treatment effect at Visit 2 
( 5.02 =θ )  
Treatment effect at Visit 3 
( 03 =θ ) 
 MSE (*100) Ratio** 95% coverage  MSE (*100) Ratio** 95% coverage  MSE (*100) Ratio** 95% coverage 
Complete Dataset            
MEM 3.6191 1.11 95.80%  3.8061 1.05 94.90%  3.9488 1.02 95.40% 
GEE 3.6191 1.10 95.60%  3.8061 1.04 94.70%  3.9488 1.00 95.00% 
MCAR Dataset*            
MEM 4.9359 1.07 95.30%  5.1385 1.03 94.50%  5.0962 1.03 94.90% 
GEE 4.9453 1.05 95.00%  5.1340 1.01 94.50%  5.1000 1.01 94.70% 
LOCF + MEM 11.6432 1.37 70.30%  5.2797 0.83 91.00%  7.1774 0.91 85.10% 
LOCF + GEE 11.6432 1.06 58.60%  5.2797 0.93 92.60%  7.1774 0.97 86.30% 
MI + MEM 9.4530 1.71 87.20%  3.8647 1.54 97.20%  4.4604 1.57 96.90% 
MI + GEE 9.4530 1.69 86.60%  3.8647 1.53 97.20%  4.4604 1.55 96.80% 
MAR Dataset*            
MEM 4.6790 1.12 96.00%  4.3223 1.03 94.90%  4.8731 1.01 95.10% 
GEE 4.6944 1.10 95.60%  4.3023 1.01 94.60%  4.8848 0.99 94.60% 
LOCF + MEM 11.6051 1.53 71.80%  7.2085 0.92 85.20%  6.0139 0.92 89.10% 
LOCF + GEE 11.6051 1.13 58.60%  7.2085 1.04 87.80%  6.0139 1.00 90.70% 
MI + MEM 8.3919 1.66 89.30%  3.9587 1.19 96.80%  3.9990 1.45 97.60% 
MI + GEE 8.3919 1.64 89.10%  3.9587 1.17 96.70%  3.9990 1.43 97.60% 
MNAR Dataset*            
MEM 15.8586 1.08 49.10%  7.1624 1.02 80.70%  3.3981 1.01 94.40% 
GEE 15.6176 1.06 48.80%  7.1599 0.99 79.80%  3.4135 0.98 93.40% 
LOCF + MEM 28.0895 1.43 6.50%  13.5904 0.82 46.50%  3.3133 0.77 91.10% 
LOCF + GEE 28.0895 1.13 3.40%  13.5904 0.92 50.10%  3.3133 0.81 91.40% 
MI + MEM 31.6730 1.93 9.40%  9.0015 1.77 72.10%  1.9354 1.67 98.50% 
MI + GEE 31.6730 1.91 9.30%  9.0015 1.75 71.50%  1.9354 1.65 98.50% 
*MCAR, missing completely at random; MAR, missing at random; MNAR, missing not at random. 
**Ratio of the mean estimated variance by each method to the corresponding sampling variance. 
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Table 3. Estimating gender effects on physical function in patients with type 2 diabetes mellitus who practiced qigong 
 Female effect at Visit 1  Female effect at Visit 2  Female effect at Visit 3 
 Estimate** 
Standard 
error p-value  Estimate** 
Standard 
error p-value  Estimate** 
Standard 
error p-value 
Raw Dataset            
MEM 3.0628 1.7868 0.090  4.3170 1.7868 0.018  3.2048 1.7975 0.078 
GEE 3.0626 1.6966 0.071  4.3168 1.7914 0.016  3.2024 1.8043 0.076 
MCAR Dataset*            
MEM 3.4870 1.9215 0.074  4.3178 1.8785 0.025  3.6058 1.9063 0.063 
GEE 3.4411 1.7276 0.046  4.3347 1.8447 0.019  3.5857 1.8418 0.052 
LOCF + MEM 4.1251 1.6658 0.015  4.0526 1.6658 0.017  4.0204 1.6658 0.018 
LOCF + GEE 4.1251 1.4786 0.005  4.0526 1.7760 0.022  4.0204 1.7189 0.019 
MI + MEM 2.7812 1.9229 0.150  3.6419 1.8846 0.055  2.8869 2.0863 0.173 
MI + GEE 2.7812 1.8737 0.140  3.6419 1.8344 0.048  2.8869 2.0411 0.164 
MAR Dataset*            
MEM 2.3189 2.0224 0.256  5.0998 2.1203 0.019  2.6264 2.2248 0.243 
GEE 2.3155 1.9786 0.242  5.1311 2.0550 0.013  2.4232 2.1134 0.252 
LOCF + MEM 1.4898 2.0222 0.463  1.9871 2.0451 0.334  1.4905 2.0451 0.468 
LOCF + GEE 1.4899 1.8861 0.430  1.9890 1.9037 0.296  1.4924 2.0128 0.458 
MI + MEM 0.9268 2.0234 0.648  3.0100 2.1645 0.170  2.4564 2.1740 0.264 
MI + GEE 0.9268 1.9731 0.639  3.0100 2.1175 0.161  2.4564 2.1272 0.254 
MNAR Dataset*            
MEM 2.3996 1.4315 0.098  2.8895 1.4515 0.051  0.8918 1.4567 0.543 
GEE 2.4161 1.3889 0.082  2.8953 1.3860 0.037  0.8893 1.4136 0.529 
LOCF + MEM 3.1927 1.3997 0.025  1.5261 1.3997 0.278  0.4391 1.3997 0.754 
LOCF + GEE 3.1927 1.4243 0.025  1.5261 1.3386 0.254  0.4391 1.3544 0.746 
MI + MEM 2.3577 1.5284 0.129  2.9356 1.3302 0.027  1.3167 1.5105 0.387 
MI + GEE 2.3577 1.4949 0.121  2.9356 1.2914 0.023  1.3167 1.4766 0.376 
*MCAR, missing completely at random; MAR, missing at random; MNAR, missing not at random. 
**Females over males. 
